SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes
9 references·0 citing·31 second hop
An Evaluation of Cost Sharing to Finance a Diet and Physical Activity Intervention to Prevent Diabetes (2006)An Evaluation of Cost Sharing to Finance …The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance (2005)The Cost-Effectiveness of Lif…Methods for the Economic Evaluation of Health Care Programmes (2005)Methods for the Economic Eval…Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes (2003)Within-Trial Cost-Effectivene…The Business Case For Quality: Case Studies And An Analysis (2003)The Business Case For Quality…Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program (2003)Costs Associated With the Pri…Valuing Health-Related Quality of Life in Diabetes (2002)Valuing Health-Related Qualit…Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes (2002)Cost-effectiveness of Intensi…Recommendations of the Panel on Cost-effectiveness in Health and Medicine (1996)Recommendations of the Panel …Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Cost-Effectiveness in Health and Medicine (1996)Clinical Outcomes and Cost-Effectiveness of Strategies for Managing People at High Risk for Diabetes (2005)Cost-Effectiveness of the Interventions in the Primary Prevention of Diabetes Among Asian Indians (2007)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review (2010)The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention (2012)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Recommendations for Reporting Cost-effectiveness Analyses (1996)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)Health status: types of validity and the index of well-being. (1976)Multi-Attribute Health Status Classification Systems (1995)EuroQol: the current state of play (1996)Correlates of health-related quality of life in type 2 diabetes (2006)Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis (2010)Five‐Hundred Life‐Saving Interventions and Their Cost‐Effectiveness (1995)Lifestyle Interventions Are Cost-Effective in People With Different Levels of Diabetes Risk (2006)Economic Evaluation of Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force (2015)The estimation of a preference-based measure of health from the SF-36 (2002)Systematic reviews: CRD's guidance for undertaking reviews in health care (2010)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)A systematic review of the use of economic evaluation in local decision-making (2008)Measuring Efficiency: The Association Of Hospital Costs And Quality Of Care (2009)Mental disorders and medical comorbidity. (2011)Patient Perceptions of Quality of Life With Diabetes-Related Complications and Treatments (2007)Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications (2013)Utility Valuations for Outcome States of Colorectal Cancer (1999)Medicare and Cost-Effectiveness Analysis (2005)Improving Decision Analyses: Parent Preferences (Utility Values) for Pediatric Health Outcomes (2009)
this work references cited by second hop

References

  • 2005Methods for the Economic Evaluation of Health Care Programmes13,647 cited
  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,455 cited
  • 2005The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance703 cited
  • 2002Cost-effectiveness of Intensive Glycemic Control, Intensified Hypertension Control, and Serum Cholesterol Level Reduction for Type 2 Diabetes507 cited
  • 2002Valuing Health-Related Quality of Life in Diabetes380 cited
  • 2003The Business Case For Quality: Case Studies And An Analysis365 cited
  • 2003Costs Associated With the Primary Prevention of Type 2 Diabetes Mellitus in the Diabetes Prevention Program358 cited
  • 2003Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes262 cited
  • 1996Recommendations of the Panel on Cost-effectiveness in Health and Medicine235 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work